News

Current Position of Venetoclax in the Treatment of AML −⁠ Hope for a Better Prognosis?

27. 2. 2023 Source: Acute Myeloid Leukemia

The treatment of acute myeloid leukemia (AML) remained stagnant for a long time, with many new drugs emerging only in the past few years. One of the newest and most important is the Bcl-2 anti-apoptotic protein inhibitor venetoclax.

Venetostart –⁠ The First Comprehensive Mobile Application with Practical Information for Venetoclax Treatment

Abbvie has developed the comprehensive mobile application Venetostart with practical information needed in clinical practice for administering venetoclax (Venclyxto), which is indicated for the…

27. 2. 2023 Source: Chronic Lymphocytic Leukemia

INFOGRAPHIC: Which treatment to choose in the 1st line for a patient with type 2 diabetes?

Diabetes mellitus is a complex chronic disease that requires continuous treatment and a strategy to reduce associated risks beyond mere glycemic control. Comorbidities and the risk of complications are...

24. 2. 2023 Source: Diabetes

Is exposure to mite allergens in breast milk or house dust a risk factor for asthma and allergies in childhood?

Exposure to mite allergens occurs early in life from both breast milk and house dust (especially bedding). The study presented below examined the impact of exposure to the dominant mite allergen Der p...

23. 2. 2023 Source: Dust Mite Allergy

Sonicare Technology as a Modern Means for Good Oral Hygiene

Sonicare technology was developed and introduced to the market by Philips 30 years ago. Since then, the range of products has expanded, and the use of sonic technology has become accessible to a wide…

23. 2. 2023 Source: Dental Care

Technology as an Aid in Home Oral Care

Good oral hygiene is a prerequisite for good health, both in the mouth area and in terms of overall condition. To make it more effective and easier, it is now possible to use technologically advanced...

22. 2. 2023 Source: Dental Care

Romiplostim in Newly Diagnosed or Persistent ITP

Thrombopoietin receptor agonists (TPO-RA) are now recommended for patients with newly diagnosed immune thrombocytopenia (ITP) or persistent ITP who have failed treatment with corticosteroids or…

21. 2. 2023 Source: Immune Thrombocytopenia

Initial Treatment for Newly Diagnosed ITP Patients at a Glance

The revised international consensus on the management of primary immune thrombocytopenia (ITP) from 2019 outlines several points summarizing suitable initial treatment for newly diagnosed individuals…

21. 2. 2023 Source: Immune Thrombocytopenia

Treatment of Diabetes in Pregnancy with Metformin Does Not Increase the Risk of Low Birth Weight

In several studies, it has been observed that exposure to metformin during pregnancy, compared to insulin exposure, is associated with an increased relative risk of the newborn being small for…

21. 2. 2023 Source: Modern Treatment of Diabetes

Current Legislative Changes Relating to Medical Devices –⁠ Overview Summary in a Nutshell

In 2022, several legislative changes were introduced in the area of medical devices (MD) for moist wound care. We are summarizing the news from three sectors, as presented by Mgr. Jan Zahálka at the…

21. 2. 2023 Source: Wound Healing

What are the patients' needs during acute phase schizophrenia therapy and how to increase their adherence?

Treatment of an acute episode of schizophrenia usually requires hospitalization in a psychiatric ward. Even though hospitalization causes discomfort and represents a burden for many patients, it…

21. 2. 2023 Source: Modern Treatment of Schizophrenia

Summary of Czech Recommendations for the Diagnosis and Treatment of Schizophrenia in Children and Adolescents 2022

In June 2022, the Psychiatric Society of the Czech Medical Association JEP updated its recommendations for the diagnosis and treatment of schizophrenia in children and adolescents. This is the first…

21. 2. 2023 Source: Modern Treatment of Schizophrenia

Efficacy and Safety of Two Pharmacokinetically-Driven Prophylactic Regimens in People with Hemophilia A

Standard prophylaxis for bleeding in hemophilia A, based on the administration of coagulation factor VIII (FVIII), depends on the patient's weight, the severity of the coagulation factor deficiency,…

20. 2. 2023 Source: Hemophilia

How can inosine pranobex help with viral infections?

Inosine pranobex has long been used for its immunomodulatory and antiviral effects in the prophylaxis and therapy of various viral infections. Below we summarize its mechanism of action, indications,…

16. 2. 2023 Source: Viral infections

What has clinical research on the effects of inosin pranobex revealed, and what does it mean for practice?

Inosin pranobex, as an antiviral drug that modulates cellular and humoral immunity, is used in the treatment of many viral infections. It is employed in diseases caused by herpetic viruses,…

16. 2. 2023 Source: Viral infections

1 … 34 35 36 37 38 … 115

Back Filter by speciality

Remove filters